Proctor and Gamble Stock - Common Errors

When looking to make an investment Proctor and Gamble stock, some investors might consider what is in or what is hot. This is why gold has recently been in an incredible bull run (which is now longer), and why the apartment was hot before. Much of this can be seen as a result of speculative piles in the sector. Another strategy is to invest in familiar with the products you known brands Proctor and Gamble stock. With this in mind, let's take a look at two brands that are very close to home for millions of consumers manufacturers of household products Procter & Gamble (NYSE: PEG FREE Stock Trend Analysis) and Johnson & Johnson (NYSE: JNI).

Proctor and Gamble stock Mistake:

Comparing these two companies, we will see the last 12 months or behavior on the market. In this way, we avoid a long history of the company, and instead of Proctor and Gamble stock taking more than one approach of "what you have done for me lately. Unlike the average return of the S & P 2013, Procter & Gamble had a decent last 12 months. The company started in 2013 to about $ 68.00 per share. Later this year, the company rose to $ 85.21, before settling around $ 80.54 in the most Proctor and Gamble stock recent operations. Even if a jump to $ 85.0 $ 68.00 would be a good profit by 25 percent, it would still be below the returns on the S & P and DOD in 2013. In addition, this population appears to have been shedding value at the end of the year, just when the whole market was stronger.

Proctor and Gamble stock with the DOD down in early 2014, and the potential for growth in 2014 far elusive, it is difficult to see exactly where Procter and Gamble will arrive this year. Johnson & Johnson began in 2013 at a price of $ 71.50. It was a break in a trading range of $ 60 to $ 65.00 to the population observed since mid 2010 to mid 2012. The action followed a more or less upward trend, reaching 93.45 in July 2013, an increase Proctor and Gamble stock of 30%. The pushed a little action, but remained strong for the rest of the year, closing at just under $ 93.00 in recent trading.

Both Procter & Gamble and Johnson & Johnson have divisions that focus on the manufacture of household products. What sets them apart from Proctor and Gamble stock others, however, are additional business divisions of business and the way businesses are run. Although Johnson & Johnson has had the best career of stock last year, the company also had a significant number of recent high-profile trial. These demands have led Installs $ 2.2 billion in November, the company achieved regarding complaints about the marketing of prescription drugs not approved for Proctor and Gamble stock several of Johnson & Johnson.